Please sign in to follow a disease.
Silence Therapeutics plc
Clinical trials sponsored by Silence Therapeutics plc, explained in plain language.
Biotech developing RNAi therapeutics for various diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New RNA drug aims to reduce blood removal in polycythemia vera patients Results expected Sep 2026 (estimated) May already have reported ↗